Odds ratio (95% CI) for developing metabolic syndrome in women without it at baseline according to changes in CRP levels
| CRP change . | n . | Model 1 . | Model 2 . | Model 3 . | Model 4 . | Model 5 . | Model 6 . |
|---|---|---|---|---|---|---|---|
| <0 mg/l | 41 | 1 | 1 | 1 | 1 | 1 | 1 |
| 0–1 mg/l | 26 | 4.5 (1.4–14.3) | 2.7 (0.8–9.3) | 3.7 (1.1–12.3) | 3.9 (1.2–12.9) | 6.1 (1.6–23.8) | 5.2 (1.6–17.4) |
| >1 mg/l | 25 | 6.2 (1.9–19.9) | 4.4 (1.3–15.0) | 4.7 (1.4–15.6) | 5.8 (1.8–19.0) | 8.2 (2.2–31.5) | 7.5 (2.2–25.6) |
| P for trend | 0.002 | 0.018 | 0.010 | 0.003 | 0.002 | 0.001 |
| CRP change . | n . | Model 1 . | Model 2 . | Model 3 . | Model 4 . | Model 5 . | Model 6 . |
|---|---|---|---|---|---|---|---|
| <0 mg/l | 41 | 1 | 1 | 1 | 1 | 1 | 1 |
| 0–1 mg/l | 26 | 4.5 (1.4–14.3) | 2.7 (0.8–9.3) | 3.7 (1.1–12.3) | 3.9 (1.2–12.9) | 6.1 (1.6–23.8) | 5.2 (1.6–17.4) |
| >1 mg/l | 25 | 6.2 (1.9–19.9) | 4.4 (1.3–15.0) | 4.7 (1.4–15.6) | 5.8 (1.8–19.0) | 8.2 (2.2–31.5) | 7.5 (2.2–25.6) |
| P for trend | 0.002 | 0.018 | 0.010 | 0.003 | 0.002 | 0.001 |
Model 1: adjusted for age, smoking, the use of drugs for hypercholesterolemia, hormone replacement therapy, and cardiovascular diseases at baseline. Model 2: adjusted for variables in model 1 and change in waist circumference during follow-up. Model 3: adjusted for variables in model 1 and change in triglycerides during follow-up. Model 4: adjusted for variables in model 1 and change in HDL cholesterol during follow-up. Model 5: adjusted for variables in model 1 and change in blood glucose during follow-up. Model 6: adjusted for variables in model 1 and change in systolic blood pressure during follow-up.